What is Wisedocs?
Founded in 2018, Wisedocs operates at the intersection of artificial intelligence and healthcare administration. The company provides a sophisticated platform that utilizes advanced optical character recognition to transform unstructured medical data into actionable insights. This technology is critical for the IME, diagnostics, medico-legal, and insurance sectors, where the manual processing of medical records has historically been a significant bottleneck. By automating these workflows, Wisedocs enables insurance carriers and legal professionals to reduce operational overhead while improving the accuracy and speed of their decision-making processes. The company's market position is bolstered by its ability to integrate seamlessly into existing enterprise SaaS environments, making it a vital partner for organizations seeking digital transformation in document-heavy workflows.
How much funding has Wisedocs raised?
Wisedocs has raised a total of $13.6M across 2 funding rounds:
Angel/Seed
$4.1M
Series A
$9.5M
Angel/Seed (2022): $4.1M with participation from GreenSky Capital and Ripple Ventures
Series A (2024): $9.5M led by ManchesterStory Group, Information Venture Partners, and Thomson Reuters Ventures
Key Investors in Wisedocs
ManchesterStory Group
ManchesterStory is a leading early-stage venture capital firm focused on deploying strategic capital to fuel growth and long-term partnerships in the financial services, healthcare, and insurance sectors.
Information Venture Partners
Information Venture Partners is a venture capital firm focusing on startups driven by dedicated founders addressing significant challenges in FinTech and Enterprise SaaS.
Thomson Reuters Ventures
Thomson Reuters Ventures is a venture capital fund focused on early-stage enterprise technology companies, leveraging the extensive resources and expertise of Thomson Reuters to accelerate growth.
What's next for Wisedocs?
With the successful closure of its latest financing round, Wisedocs is poised to enter a new phase of enterprise-level growth. The strategic backing from industry-focused venture firms suggests a roadmap centered on product development and market penetration within the North American insurance sector. Future initiatives will likely focus on scaling the platform's capabilities to handle increasingly complex medical datasets, while simultaneously expanding its footprint among global financial and legal institutions. As the company matures, the focus will shift toward deepening its integration with major insurance carriers and enhancing its AI models to maintain a competitive edge in the rapidly evolving landscape of automated medical data management.
See full Wisedocs company page
